Association of Clinical and Pathologic Variables with Lumpectomy Surgical Margin Status after Preoperative Diagnosis or Excisional Biopsy of Invasive Breast Cancer

PurposeTo evaluate the impact of preoperative diagnosis in obtaining negative lumpectomy margins.Materials and MethodsFive hundred and thirty five patients who underwent breast conserving therapy for stage I/II cancer from 1971 to 1996 were included in this IRB-approved retrospective analysis. Three hundred and ninety five patients had a defined inked margin status after initial excision. The following factors were evaluated for correlation with margins at initial excision: age (< or >45), grade (3/1 or 2), family history (present/absent), histology (lobular/other), estrogen receptor (ER) status, presence of extensive intraductal carcinoma (EIC), presence of lymphovascular invasion (LVI), and biopsy type (excisional/preoperative).ResultsBiopsy type (P < 0.0001), EIC (P = 0.002), ER status (P = 0.02), lobular histology (P = 0.02) and age (P = 0.02) were significantly correlated with initial margin status among the entire group. For patients who underwent preoperative diagnostic biopsy, 52% (35/67) had negative initial margins as compared to 29% (94/328) for excisional biopsy. Among patients who underwent preoperative biopsy, only lobular histology (P = 0.04) and LVI (P = 0.04) were related to initial margin status. The rate of re-excision was 34% for patients diagnosed preoperatively versus 61% with excisional biopsy (P < 0.0001). The percentage of patients with negative final margin status was similar with either core/needle or excisional biopsy (79 and 78%, respectively).ConclusionsPreoperative diagnosis is the most significant predictor of initial margin status in patients undergoing breast conservation. Patients with lobular histology may require improved preoperative and/or intraoperative assessment to increase the rate of negative margins at initial excision.

[1]  P. Schneider,et al.  Cost-Benefit Analysis of Biopsy Methods for Suspicious Mammographic Lesions , 2001 .

[2]  S. Jeffrey,et al.  The importance of the lumpectomy surgical margin status in long term results of breast conservation , 1995, Cancer.

[3]  G. Porter,et al.  Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins , 2005, Journal of surgical oncology.

[4]  H. Verkooijen Diagnostic accuracy of stereotactic large‐core needle biopsy for nonpalpable breast disease: Results of a multicenter prospective study with 95% surgical confirmation , 2002, International journal of cancer.

[5]  L. Rybicki,et al.  A prospective review of the decline of excisional breast biopsy. , 2002, American journal of surgery.

[6]  A. O'Doherty,et al.  Intraoperative margin assessment and re-excision rate in breast conserving surgery. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[7]  R. J. Jackman,et al.  Stereotactic histologic biopsy with patients prone: technical feasibility in 98% of mammographically detected lesions. , 2003, AJR. American journal of roentgenology.

[8]  H. D. de Koning,et al.  Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy , 2004, British Journal of Cancer.

[9]  Rex C. Bentley,et al.  Impact of Core-Needle Breast Biopsy on the Surgical Management of Mammographic Abnormalities , 2001, Annals of surgery.

[10]  G. Porter,et al.  Ten years of breast screening in the Nova Scotia Breast Screening Program, 1991-2001. experience: use of an adaptable stereotactic device in the diagnosis of screening-detected abnormalities. , 2005, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[11]  W. Symmans,et al.  The incidence of positive margins with breast conserving therapy following mammotome biopsy for microcalcification , 2000, Journal of surgical oncology.

[12]  M. Takehara,et al.  Examination of breast conserving therapy in lobular carcinoma , 2004, Breast cancer.

[13]  K. Fahrbach,et al.  A comparison of the accuracy of two minimally invasive breast biopsy methods: a systematic literature review and meta-analysis , 2006, Archives of Gynecology and Obstetrics.

[14]  MRCSI Mary F. Dillon MB,et al.  A Pathologic Assessment of Adequate Margin Status in Breast-Conserving Therapy , 2006, Annals of Surgical Oncology.

[15]  M. Dillon,et al.  Identifying patients at risk of compromised margins following breast conservation for lobular carcinoma. , 2006, American journal of surgery.

[16]  J. Klaase,et al.  The continued utility of needle localised biopsy for non-palpable breast lesions. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  D. Visscher,et al.  Clinicopathologic significance of ductal carcinoma in situ in breast core needle biopsies with invasive cancer. , 2000, The American journal of surgical pathology.

[18]  R. J. Jackman,et al.  Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. , 1999, Radiology.

[19]  B. Haffty,et al.  Local recurrence of breast cancer after breast conservation therapy in patients examined by means of stereotactic core-needle biopsy. , 2002, Radiology.

[20]  M. Morrow,et al.  Prospective Comparison of Stereotactic Core Biopsy and Surgical Excision as Diagnostic Procedures for Breast Cancer Patients , 2001, Annals of surgery.

[21]  W. Mali,et al.  Impact of stereotactic large-core needle biopsy on diagnosis and surgical treatment of nonpalpable breast cancer. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[22]  J. Imbrie,et al.  Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. , 2000, Annals of surgery.

[23]  J. Norton,et al.  Mammographically detected breast cancer. Benefits of stereotactic core versus wire localization biopsy. , 1996, Annals of surgery.